
Adaptive Licensing (AL) is a flexible approach to drug development and regulation, with two live pilot schemes accepted by the European Medicines Agency (EMA). The system acknowledges that levels of uncertainty will always surround innovative treatments. Browse Full Report With TOC @ http://www.researchmoz.us/adaptive-licensing-a-holistic-approach-to-drug-development-and-regulation-report.html
http://www.researchmoz.us/adaptive-licensing-a-holistic-approach-to-drug-development-and-regulation-report.html
No comments:
Post a Comment